Is the bithiazole moiety of bleomycin a classical intercalator?

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Drug Discovery

Background:

• Bleomycin is a crucial anticancer drug, with its DNA-cleaving activity well-established.
• The precise role of the bithiazole moiety in bleomycin's biological function remains unclear.
• Understanding bithiazole-DNA interactions is key to elucidating bleomycin's mechanism of action.

Purpose of the Study:

• To synthesize bithiazole derivatives structurally analogous to bleomycin's "tripeptide S" moiety.
• To investigate the interaction of these synthesized bithiazoles with DNA.
• To elucidate the binding mode and implications of bithiazole-DNA interactions.

Main Methods:

• Synthesis of 2", 4-disubstituted bithiazoles.
• DNA interaction studies utilizing delta Tm, fluorescence quenching, Electron Paramagnetic Resonance (EPR) spectroscopy, and viscometry.
• Analysis of binding modes, including intercalation and partial insertion.

Main Results:

• Thermal melting (delta Tm) and fluorescence quenching data indicated DNA binding by the bithiazole moiety.
• These results initially suggested intercalation of the bithiazole structure between DNA base pairs.
• EPR and viscometry data revealed a more complex interaction, pointing towards partial intercalation and wedging between bases at DNA bending points.

Conclusions:

• The bithiazole moiety of bleomycin likely binds to DNA via partial intercalation.
• This binding involves the insertion of a thiazole ring between DNA bases, potentially at sites of DNA bending.
• The findings provide insights into the structural basis of bleomycin's DNA interaction and anticancer activity.